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EMG showed complete axonotmesic denervation of the right
hemifacial muscles. MRI with contrast showed enhancement in the
intratemporal part of the right facial nerve and disappearance of the
previous alteration on the left (fig. 1b). Intravenous dexamethasone
(8 mg for 5 days; 4 mg for 3 days) was given, during which time the
patient reported improved facial mobility and disappearance of local
tenderness.
Discussion
Differential diagnosis of our case considered Crohn’s disease, sar-
coidosis and Bell’s palsy [7, 13–16]. There were no signs of intestinal
disease and oral examination showed no ulceration or mucosal cob-
blestoning. We excluded sarcoidosis from the negative chest X-ray
and normal ACE in serum and CSF.
The oligoclonal banding in our patient suggests abnormal Ig pro-
duction by lymphocyte clones within the CNS, since neither serum Ig
nor blood-brain barrier alterations were present (low CSF albumin).
IgG synthesis in CSF was reported in 3/56 cases of peripheral facial
palsy, but 2 had elevated Borrelia antibodies [16].
Transient alteration along the facial nerve, detected by MRI, has
been described previously in MRS [17], while another patient with
MRS had an increased level of CSF IgG as well as oligoclonal band-
ing [18]. Our patient is the first in whom these two alterations are
associated, and although we have no proof of a causal relation
between them, in the absence of family history, collagenopathy and
sarcoidosis, they suggest a primary immune disorder of the CNS as a
possible cause of MRS.
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Case Report
In October 1994, a 25-year-old woman complained of 4 days of
progressive fatigue, retro-orbital headaches, nausea, and intermittent
vomiting. Frontal sinusitis was suspected and oral amoxicillin was
administered for 4 days. Despite therapy, the patient became somno-
lent and was referred to hospital. MRI scanning showed multiple
space-occupying lesions in the deep white matter with concomitant
edema adjacent to both frontal horns (fig. 1). After steroid treatment,
the patient’s condition improved markedly. Eighteen days after onset
of the initial symptoms she was referred to our clinic for further diag-
nostic evaluation of suspected multilocular CNS lymphoma.
On examination, she had papilledema bilaterally, and cogwheel
eye pursuit. Tendon reflexes were more pronounced to the right, but
all other findings were normal. The patient’s past medical history was
normal and she took no medication except birth control pills. Post-
contrast MRI scans showed gadolinium enhancement of all lesions
(data not shown).
Somatosensory and visually evoked potentials as well as central
motor conduction velocities were normal. CSF leukocytes were mild-
ly increased (8/Ìl; 57% lymphocytes, 39% monocytes, 2% macro-
phages and 2% granulocytes). No lymphoma cells were found. CSF
glucose was normal. CSF protein was 44 mg/dl. Isoelectric focusing
showed oligoclonal bands in the CSF. Antibodies to Borrelia burgdor-
feri were determined using an indirect immunofluorescence test after
absorption with Treponema phagedenis, as well as ELISA. IgG and
IgM titers 61:64 in serum and 61:4 in CSF are considered signifi-
cantly elevated. In comparison, the patient had a serum IgG titer
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Fig. 1. T2-weighted transverse MRI shows
multiple space-occupying lesions in the deep
white matter, adjacent to lateral ventricles.
Fig. 2. Proton-density-weighted transverse
MRI shows no substantial residual edema in
the frontal deep white matter.
1:2048, serum IgM 1:64, CSF IgG 1:64, and CSF IgM !1:2. Intrathe-
cal production of antibodies to B. burgdorferi was determined as pub-
lished previously [1]. Briefly, the CSF/serum ratio of ELISA specific
anti-B. burgdorferi IgG values was compared with the CSF/serum
ratio of total IgG (CSF/serum index). The CSF/serum index in the
patient was 3.0, indicating specific intrathecal antibody production
in the CSF. Tests for syphilis, sarcoidosis, and HIV were negative.
The patient underwent stereotaxic biopsy of the lesion in the right
frontal white matter to exclude a CNS lymphoma because of pre-
treatment with corticosteroids. Histopathological examination
showed an active inflammatory process with diffuse infiltration of
granulocytes and monocytes, reactive gliosis, and petechial erythro-
cyte extravasation, consistent with Lyme neuroborreliosis. Direct
microscopic or cultural proof of B. burgdorferi or other infectious
agents failed. PCR was not performed. On the basis of the serological
results, active Lyme disease was diagnosed. Since further microbio-
logical analyses were pending at the time, intravenous amoxicillin
was administered for 14 days to cover a potential Listeria infection.
(Listeria serology and PCR results proved negative.) An MRI scan
directly after discontinuation of therapy revealed no residual edema
(fig. 2), but minor focal gadolinium enhancement at the biopsy site
was noted, possibly related to mild gliosis (data not shown). A second
examination 6 months later detected no gadolinium enhancement.
Currently, the patient is in good health and not on treatment.
Discussion
Neurological manifestations of Lyme disease include meningitis,
encephalitis, psychiatric disorders, cranial neuritis, polyradiculitis,
and peripheral neuropathy [2]. The pathogenesis is not known, but
both vasculopathy and direct brain invasion are possible mecha-
nisms. Our patient provides an unusual example of a curable cerebral
mass lesion. Papilledema is an uncommon manifestation of neuro-
borreliosis and usually not due to elevated intracranial pressure [3].
Space-occupying lesions and pseudotumor cerebri are extremely rare
and have been described only in children up to 15 years of age [4].
Brain CT and MRI findings in patients with Lyme disease are usually
normal, but abnormalities may involve periventricular lesions simu-
lating multiple sclerosis [5, 6], hydrocephalus [7], and thalamic and
basal ganglia lesions [5, 8]. However, space-occupying, contrast-
enhancing lesions in contact with the subarachnoid space, predomi-
nantly in the cerebral hemispheres, basal ganglia, and corpus callo-
sum, are characteristic of primary CNS lymphoma [9]. Corticoste-
roids and antibiotic therapy directed against B. burgdorferi led to
complete remission of elevated intracranial pressure, as well as reso-
lution of the inflammatory lesions on MRI scans. To our knowledge,
this is the first case report of an adult patient with neuroborreliosis
mimicking CNS lymphoma in cranial MRI. Brain imaging has not
been used in previously published cases with abnormal CSF cytology
[10]. Normal evoked potential studies on presentation and the favor-
able long-term clinical course of the disease are strong arguments
against multiple sclerosis. We are not aware of any case of acute dis-
seminated encephalomyelitis associated with B. burgdorferi infec-
tion; however, the clinical syndrome of our patient meets the criteria.
As the infection can be cured, MRI may play an important role in
making the diagnosis and differentiating Lyme neuroborreliosis from
other diseases of the white matter.
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Although cranial nerves are occasionally affected in chronic
inflammatory demyelinating polyneuropathy (CIDP), involvement
of the bulbar muscles is uncommon [1–6]. Here we report a patient
with CIDP who presented with weakness of the distal upper extremi-
ties and atrophy of the tongue. The features mimicked those of motor
neuron disease. CIDP should be considered in patients who present
with bulbar palsy because it is treatable.
Case Report
A 49-year-old man developed a slowly progressive weakness of
the left hand followed by weakness of the right hand. Two years later,
he noted speech disturbance, and another year later, he noted diffi-
culty in swallowing. He was diagnosed as having motor neuron dis-
ease in our outpatient clinic because he showed atrophy of the
Table 1. Nerve conduction studies
Nerves MCV
m/s
CMAP, mV
(distal/prox.)
d.l.
ms
SCV
m/s
SNAP
ÌV
FCV
m/s
Rt. median a 1.0/n.e. 4.8 n.e. n.e. n.e.
Lt. median a 1.1/n.e. 5.3 33.0 2.0 n.e.
Rt. ulnar a 1.4/n.e. 3.4 n.e. n.e. n.e.
Lt. ulnar a 1.0/n.e. 5.0 n.e. n.e. n.e.
Rt. PTN 35.0 2.6/1.9 5.0 39.6
Lt. PTN 30.8 2.6/2.2 8.2 40.4
Rt. DPN 41.0 1.8/1.7 5.5
Lt. DPN n.e. n.e. n.e.
Rt. sural n.e. n.e.
Lt. sural 42.6 5.0
Rt = Right; Lt = left; PTN = posterior tibial nerve; DPN = deep
peroneal nerve; MCV = motor conduction velocity; CMAP = com-
pound motor action potential; d.l. = distal latency; SCV = sensory
conduction velocity; SNAP = sensory nerve action potential; FCV =
F wave conduction velocity; n.e. = not evoked.
a MCV could not be calculated due to complete conduction block
between elbow and wrist.
tongue. At age 52, he was admitted to our hospital for further investi-
gation. Neurologic examination revealed bilateral facial weakness,
absence of the gag reflex, poor palatal elevation, and moderate atro-
phy and paresis of the tongue bilaterally without fasciculations.
Moderate dysphagia and dysarthria were also noted. He showed a
dropped wrist on the left side. The Medical Research Council (MRC)
scale grade for the left forearm extensors was 1, and that for the right
was 3, with bilateral wasting and weakness of the intrinsic hand mus-
cles (MRC grades 1–2). There was mild impairment of pinprick and
light-touch sensation over the median and the ulnar nerve territories
on both sides. Muscle power in the lower extremities was preserved.
All tendon reflexes were absent.
Nerve conduction studies (table 1) showed slowing of nerve con-
duction velocities and reduced sensory and motor action potential
amplitude. Complete conduction block was seen between elbow and
wrist in the median and ulnar motor nerves on both sides. The distal
latency for the facial nerve was prolonged (6.3 ms, normal !4.0 ms.
Needle electromyography revealed a reduced interference with long-
duration polyphasic high-amplitude motor unit potentials in the
tongue, sternocleidomastoid muscle, biceps brachii muscle, and the
first dorsal interosseus muscle, indicating chronic partial denerva-
tion and reinnervation. No abnormal potentials were seen at rest.
Cerebrospinal fluid studies showed an elevated protein content
(76 mg/dl) with a normal white blood cell count. Magnetic resonance
images of the brain and the spinal cord were unremarkable. Other
laboratory studies including routine chemistries, immunoelectropho-
resis, thyroid function tests, and tests for antinuclear antigen, rheu-
matoid factor, and angiotensin-converting enzyme revealed normal
findings.
He was diagnosed as having CIDP, and was treated with high-
dose intravenous immunoglobulin at 0.4 g/kg/day for 5 days. Subse-
quently, he received 60 mg of oral prednisolone for 1 month, after
